
Our CRO pathology services adhere to stringent quality assurance protocols, ensuring that all results are reproducible and reliable, enabling your research to meet regulatory standards effectively and efficiently.
Our team comprises seasoned experts in pathology with years of experience in preclinical research, ensuring robust insights and meticulous implementation of your studies aligned with your specific needs.
KCI Biotech operates AAALAC-accredited facilities designed to accommodate various preclinical studies, providing a rich environment for comprehensive CRO pathology services tailored to diverse research demands.
We offer flexible minimum order quantities (MOQs) for our CRO pathology services, allowing clients of all sizes to access high-quality research solutions without compromising on tailoring their specific needs.





Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china